| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/01/2023 | -3.98% | Truist Securities | $48 → $47 | Maintains | Hold |
| 01/24/2023 | 12.36% | DA Davidson | $57 → $55 | Maintains | Buy |
| 11/02/2022 | 16.45% | Raymond James | $65 → $57 | Maintains | Strong Buy |
| 10/18/2022 | 12.36% | RBC Capital | $50 → $55 | Upgrades | Sector Perform → Outperform |
| 09/20/2022 | 8.27% | B of A Securities | $55 → $53 | Maintains | Neutral |
| 08/16/2022 | 32.79% | Raymond James | $70 → $65 | Maintains | Strong Buy |
| 06/29/2022 | 2.15% | Truist Securities | → $50 | Initiates Coverage On | → Hold |
| 06/27/2022 | 20.53% | DA Davidson | $66 → $59 | Maintains | Buy |
| 04/27/2022 | 22.57% | RBC Capital | $65 → $60 | Downgrades | Outperform → Sector Perform |
| 02/02/2022 | — | RBC Capital | Upgrades | Sector Perform → Outperform | |
| 10/06/2021 | — | DA Davidson | Upgrades | Neutral → Buy | |
| 08/27/2021 | 43% | Raymond James | $75 → $70 | Maintains | Strong Buy |
| 08/02/2021 | 53.22% | Raymond James | $79 → $75 | Maintains | Strong Buy |
| 04/28/2021 | 32.79% | RBC Capital | $58 → $65 | Downgrades | Outperform → Sector Perform |
| 04/28/2021 | 24.62% | BMO Capital | $58 → $61 | Downgrades | Outperform → Market Perform |
| 04/26/2021 | 61.39% | Raymond James | $61 → $79 | Maintains | Strong Buy |
| 03/17/2021 | — | DA Davidson | Downgrades | Buy → Neutral | |
| 10/01/2020 | 4.19% | Raymond James | $48 → $51 | Upgrades | Outperform → Strong Buy |
| 09/11/2020 | -1.94% | B of A Securities | → $48 | Downgrades | Buy → Neutral |
| 07/31/2020 | -1.94% | Raymond James | $38 → $48 | Maintains | Outperform |
| 07/10/2020 | -8.07% | RBC Capital | $40 → $45 | Upgrades | Sector Perform → Outperform |
| 05/04/2020 | -22.37% | Raymond James | $34 → $38 | Maintains | Outperform |
| 04/29/2020 | -8.07% | DA Davidson | $50 → $45 | Maintains | Buy |
| 01/07/2020 | -1.94% | Raymond James | → $48 | Upgrades | Market Perform → Outperform |
| 07/31/2019 | -14.2% | RBC Capital | → $42 | Downgrades | Outperform → Sector Perform |
| 04/05/2019 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 04/02/2019 | — | Seaport Global | Initiates Coverage On | → Buy | |
| 03/11/2019 | -10.11% | BMO Capital | → $44 | Upgrades | Market Perform → Outperform |
| 10/31/2018 | -10.11% | BMO Capital | $49 → $44 | Maintains | Market Perform |
| 10/30/2018 | 2.15% | DA Davidson | $52 → $50 | Upgrades | Neutral → Buy |
| 05/07/2018 | — | DA Davidson | Upgrades | Underperform → Neutral | |
| 05/07/2018 | — | RBC Capital | Upgrades | Sector Perform → Outperform | |
| 02/13/2018 | 0.1% | BMO Capital | $42 → $49 | Maintains | Market Perform |
What is the target price for PotlatchDeltic (PCH)?
The latest price target for PotlatchDeltic (NASDAQ: PCH) was reported by Truist Securities on February 1, 2023. The analyst firm set a price target for $47.00 expecting PCH to fall to within 12 months (a possible -3.98% downside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for PotlatchDeltic (PCH)?
The latest analyst rating for PotlatchDeltic (NASDAQ: PCH) was provided by Truist Securities, and PotlatchDeltic maintained their hold rating.
When is the next analyst rating going to be posted or updated for PotlatchDeltic (PCH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PotlatchDeltic, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PotlatchDeltic was filed on February 1, 2023 so you should expect the next rating to be made available sometime around February 1, 2024.
Is the Analyst Rating PotlatchDeltic (PCH) correct?
While ratings are subjective and will change, the latest PotlatchDeltic (PCH) rating was a maintained with a price target of $48.00 to $47.00. The current price PotlatchDeltic (PCH) is trading at is $48.95, which is out of the analyst's predicted range.